DirectorUniversity Children’s Hospital Zurich, Zurich, SwitzerlandZürich, Zurich, Switzerland
LB 01.1 - Efanesoctocog Alfa Prophylaxis for Previously Treated Patients <12 Years of Age With Severe Hemophilia A
Sunday, June 25, 202310:45 – 11:00 ET
OC 43.4 - Effectiveness of emicizumab under real-world conditions in patients of all ages with hemophilia A with and without FVIII inhibitors: interim analysis of the non-interventional study EMIIL
Monday, June 26, 202315:30 – 15:45 ET